Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Changing epidemiology of nontuberculous mycobacterial lung disease over the last two decades in a region of the Basque country.

Pedrero S, Tabernero E, Arana-Arri E, Urra E, Larrea M, Zalacain R.

ERJ Open Res. 2019 Nov 4;5(4). pii: 00110-2018. doi: 10.1183/23120541.00110-2018. eCollection 2019 Oct.

2.

FACTORS INFLUENCING LONG-TERM SURVIVAL AFTER HOSPITALIZATION WITH PNEUMOCOCCAL PNEUMONIA.

Ruiz LA, Serrano L, España PP, Martinez-Indart L, Gómez A, Uranga A, Castro S, Artaraz A, Zalacain R.

J Infect. 2019 Nov 5. pii: S0163-4453(19)30338-X. doi: 10.1016/j.jinf.2019.10.024. [Epub ahead of print]

PMID:
31704242
3.

Evolution of serotypes in bacteremic pneumococcal adult pneumonia in the period 2001-2014, after introduction of the pneumococcal conjugate vaccine in bizkaia (spain).

España PP, Uranga A, Ruiz LA, Quintana JM, Bilbao A, Aramburu A, Serrano L, Ayarza R, Martinez AP, Zalacain R.

Vaccine. 2019 Jun 27;37(29):3840-3848. doi: 10.1016/j.vaccine.2019.05.052. Epub 2019 May 29.

PMID:
31153692
4.

Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study.

Ruiz LA, España PP, Gómez A, Bilbao A, Jaca C, Arámburu A, Capelastegui A, Restrepo MI, Zalacain R.

BMC Geriatr. 2017 Jun 20;17(1):130. doi: 10.1186/s12877-017-0518-0.

5.

Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcome.

Menéndez R, Montull B, Reyes S, Amara-Elori I, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, Rodríguez de Castro F, Rello J, Molinos L, Ruiz-Manzano J, Torres A.

J Infect. 2016 Nov;73(5):419-426. doi: 10.1016/j.jinf.2016.08.001. Epub 2016 Aug 6.

PMID:
27506395
6.

Age-related risk factors for bacterial aetiology in community-acquired pneumonia.

Sahuquillo-Arce JM, Menéndez R, Méndez R, Amara-Elori I, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, de Castro FR, Rello J, Molinos L, Ruiz-Manzano J, Torres A.

Respirology. 2016 Nov;21(8):1472-1479. doi: 10.1111/resp.12851. Epub 2016 Jul 14.

PMID:
27417291
7.

[Practical use of pneumococcal antigen assessment in urine].

Zalacain R.

Med Clin (Barc). 2016 Apr 15;146(8):348-9. doi: 10.1016/j.medcli.2016.01.001. Epub 2016 Feb 17. Spanish. No abstract available.

PMID:
26897502
8.

Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia.

Montull B, Menéndez R, Torres A, Reyes S, Méndez R, Zalacaín R, Capelastegui A, Rajas O, Borderías L, Martin-Villasclaras J, Bello S, Alfageme I, Rodríguez de Castro F, Rello J, Molinos L, Ruiz-Manzano J; NAC Calidad Group.

PLoS One. 2016 Jan 4;11(1):e0145929. doi: 10.1371/journal.pone.0145929. eCollection 2016.

9.

Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia.

Molinos L, Zalacain R, Menéndez R, Reyes S, Capelastegui A, Cillóniz C, Rajas O, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, Rodríguez de Castro F, Rello J, Ruiz-Manzano J, Gabarrús A, Musher DM, Torres A.

Ann Am Thorac Soc. 2015 Oct;12(10):1482-9. doi: 10.1513/AnnalsATS.201505-304OC.

PMID:
26288389
10.

Bacterial pneumonia in older people.

Ruiz LA, Gómez A, Zalacain R.

J Gerontol A Biol Sci Med Sci. 2015 May;70(5):663. doi: 10.1093/gerona/glv021. No abstract available.

PMID:
25855764
11.

A new biomarker panel in bronchoalveolar lavage for an improved lung cancer diagnosis.

Uribarri M, Hormaeche I, Zalacain R, Lopez-Vivanco G, Martinez A, Nagore D, Ruiz-Argüello MB.

J Thorac Oncol. 2014 Oct;9(10):1504-12. doi: 10.1097/JTO.0000000000000282.

12.

Pneumococcal pneumonia: differences according to blood culture results.

Capelastegui A, Zalacain R, Bilbao A, Egurrola M, Iturriaga LA, Quintana JM, Gomez A, Esteban C, España PP.

BMC Pulm Med. 2014 Aug 5;14:128. doi: 10.1186/1471-2466-14-128.

13.

Streptococcus pneumoniae antigen in urine: diagnostic usefulness and impact on outcome of bacteraemic pneumococcal pneumonia in a large series of adult patients.

Zalacain R, Capelastegui A, Ruiz LA, Bilbao A, Gomez A, Uranga A, España PP.

Respirology. 2014 Aug;19(6):936-43. doi: 10.1111/resp.12341. Epub 2014 Jun 26.

14.

Tobacco smoking increases the risk for death from pneumococcal pneumonia.

Bello S, Menéndez R, Antoni T, Reyes S, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martin-Villasclaras JJ, Alfageme I, Rodríguez de Castro F, Rello J, Luis M, Ruiz-Manzano J.

Chest. 2014 Oct;146(4):1029-1037. doi: 10.1378/chest.13-2853.

PMID:
24811098
15.

Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study.

Huerta A, Soler N, Esperatti M, Guerrero M, Menendez R, Gimeno A, Zalacaín R, Mir N, Aguado JM, Torres A.

Respir Res. 2014 Feb 11;15:17. doi: 10.1186/1465-9921-15-17.

16.

Bacteremic pneumococcal pneumonia in elderly and very elderly patients: host- and pathogen-related factors, process of care, and outcome.

Ruiz LA, Zalacain R, Capelastegui A, Bilbao A, Gomez A, Uranga A, España PP.

J Gerontol A Biol Sci Med Sci. 2014 Aug;69(8):1018-24. doi: 10.1093/gerona/glt288. Epub 2014 Jan 27.

PMID:
24470128
17.

Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.

Polverino E, Torres A, Menendez R, Cillóniz C, Valles JM, Capelastegui A, Marcos MA, Alfageme I, Zalacain R, Almirall J, Molinos L, Bello S, Rodríguez F, Blanquer J, Dorado A, Llevat N, Rello J; HCAP Study investigators.

Thorax. 2013 Nov;68(11):1007-14. doi: 10.1136/thoraxjnl-2013-203828. Erratum in: Thorax. 2015 Jul;70(7):708.

PMID:
24130227
18.

Compliance with guidelines-recommended processes in pneumonia: impact of health status and initial signs.

Menéndez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Rajas O, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, de Castro FR, Rello J, Molinos L, Ruiz-Manzano J.

PLoS One. 2012;7(5):e37570. doi: 10.1371/journal.pone.0037570. Epub 2012 May 22.

19.

Initial management of pneumonia and sepsis: factors associated with improved outcome.

Menéndez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, de Castro FR, Rello J, Molinos L, Ruiz-Manzano J.

Eur Respir J. 2012 Jan;39(1):156-62. doi: 10.1183/09031936.00188710. Epub 2011 Aug 4.

20.

Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay.

Ruiz LA, Gómez A, Jaca C, Martínez L, Gómez B, Zalacain R.

Infection. 2010 Dec;38(6):453-8. doi: 10.1007/s15010-010-0058-4. Epub 2010 Sep 29.

PMID:
20878457
21.

[The CRB-65 scale in pneumonia in the elderly].

Zalacain R.

Med Clin (Barc). 2010 Jun 19;135(3):115-7. doi: 10.1016/j.medcli.2009.11.040. Epub 2010 Feb 11. Spanish. No abstract available.

PMID:
20152997
22.

Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia.

España PP, Capelastegui A, Quintana JM, Bilbao A, Diez R, Pascual S, Esteban C, Zalacaín R, Menendez R, Torres A.

J Infect. 2010 Feb;60(2):106-13. doi: 10.1016/j.jinf.2009.11.013. Epub 2009 Dec 2. Review.

PMID:
19961875
23.

Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia.

Capelastegui A, España PP, Quintana JM, Bilbao A, Menendez R, Zalacain R, Torres A.

Thorax. 2009 Jun;64(6):496-501. doi: 10.1136/thx.2008.098814. Epub 2009 Feb 22.

PMID:
19237392
24.

Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.

Yandiola PPE, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, Zalacain R, Menendez R, Torres A.

Chest. 2009 Jun;135(6):1572-1579. doi: 10.1378/chest.08-2179. Epub 2009 Jan 13.

PMID:
19141524
25.

Escherichia coli: an unknown and infrequent cause of community acquired pneumonia.

Ruiz LA, Zalacain R, Gómez A, Camino J, Jaca C, Núñez JM.

Scand J Infect Dis. 2008;40(5):424-7. doi: 10.1080/00365540701732913.

PMID:
18418804
26.

Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study.

Miravitlles M, Zalacain R, Murio C, Ferrer M, Alvarez-Sala JL, Masa JF, Verea H, Ros F, Vidal R; IMPAC Study Group (see page 448).

Clin Drug Investig. 2003;23(7):439-50.

PMID:
17535055
27.

[Antimicrobial treatment of COPD in the elderly].

Torres Martí A, Quintano Jiménez JA, Martínez Ortiz de Zárate M, Rodríguez Pascual C, Prieto J, Zalacaín R.

Rev Esp Quimioter. 2006 Jun;19(2):167-83. Spanish. No abstract available.

28.

Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome.

Menéndez R, Torres A, Zalacaín R, Aspa J, Martín-Villasclaras JJ, Borderías L, Benítez-Moya JM, Ruiz-Manzano J, de Castro FR, Blanquer J, Pérez D, Puzo C, Sánchez-Gascón F, Gallardo J, Alvarez C, Molinos L; NEUMOFAIL Group.

Am J Respir Crit Care Med. 2005 Sep 15;172(6):757-62. Epub 2005 Jun 3.

PMID:
15937289
29.

[Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)].

Alfageme I, Aspa J, Bello S, Blanquer J, Blanquer R, Borderías L, Bravo C, de Celis R, de Gracia X, Dorca J, Gallardo J, Gallego M, Menéndez R, Molinos L, Paredes C, Rajas O, Rello J, Rodríguez de Castro F, Roig J, Sánchez-Gascón F, Torres A, Zalacaín R; Grupo de Estudio de la Neumonía Adquirida en la Comunidad. Area de Tuberculosis e Infecciones Respiratorias (TIR)-SEPAR.

Arch Bronconeumol. 2005 May;41(5):272-89. Review. Spanish. No abstract available.

30.

Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.

Rosell A, Monsó E, Soler N, Torres F, Angrill J, Riise G, Zalacaín R, Morera J, Torres A.

Arch Intern Med. 2005 Apr 25;165(8):891-7.

PMID:
15851640
31.

Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients.

Menéndez R, Torres A, Rodríguez de Castro F, Zalacaín R, Aspa J, Martín Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Blanquer J, Pérez D, Puzo C, Sánchez-Gascón F, Gallardo J, Alvarez CJ, Molinos L; Neumofail Group.

Clin Infect Dis. 2004 Dec 15;39(12):1783-90. Epub 2004 Nov 18.

PMID:
15578400
32.

Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome.

Menéndez R, Torres A, Zalacaín R, Aspa J, Martín Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Rodríguez de Castro F, Blanquer J, Pérez D, Puzo C, Sánchez Gascón F, Gallardo J, Alvarez C, Molinos L; Neumofail Group.

Thorax. 2004 Nov;59(11):960-5.

33.

Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study.

Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, Verea H, Murio C, Ros F, Vidal R; IMPAC Study Group.

Thorax. 2004 May;59(5):387-95.

34.

[Where should acquired community pneumonia be treated?].

Zalacain R.

Med Clin (Barc). 2004 Apr 10;122(13):496-8. Spanish. No abstract available.

PMID:
15104945
35.

[Bronchial carcinoid tumors. Analysis of 41 cases].

Gómez A, Zalacain R, Cabriada V, López L, Cancelo L, Jaca C.

Rev Clin Esp. 2004 Apr;204(4):202-5. Spanish.

PMID:
15104929
36.

Drug-resistant pneumococcal pneumonia: clinical relevance and related factors.

Aspa J, Rajas O, Rodríguez de Castro F, Blanquer J, Zalacain R, Fenoll A, de Celis R, Vargas A, Rodríguez Salvanés F, España PP, Rello J, Torres A; Pneumococcal Pneumonia in Spain Study Group.

Clin Infect Dis. 2004 Mar 15;38(6):787-98. Epub 2004 Mar 1.

PMID:
14999620
37.

[Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases].

Benito JR, Montejo JM, Cancelo L, Zalacaín R, López L, Fernández Gil de Pareja J, Alonso E, Oñate J.

Enferm Infecc Microbiol Clin. 2003 Oct;21(8):394-400. Review. Spanish.

PMID:
14525703
38.

Community-acquired pneumonia in the elderly: Spanish multicentre study.

Zalacain R, Torres A, Celis R, Blanquer J, Aspa J, Esteban L, Menéndez R, Blanquer R, Borderías L; Pneumonia in the elderly working group, Area de Tuberculosis e Infecciones Respiratorias.

Eur Respir J. 2003 Feb;21(2):294-302.

39.

[Diagnostic methods and treatment of community-acquired pneumonia in Spain: NACE study].

Celis MR, Torres A, Zalacaín R, Aspa J, Blanquer J, Blanquer R, Gallardo J, España PP; Grupo de trabajo del Area TIR para el estudio del diagnóstico y tratamiento de la NAC en España (NACE).

Med Clin (Barc). 2002 Sep 21;119(9):321-6. Spanish.

PMID:
12356360
40.

Treatment and quality of life in patients with chronic obstructive pulmonary disease.

Miravitlles M, Alvarez-Sala JL, Lamarca R, Ferrer M, Masa F, Verea H, Zalacain R, Murio C, Ros F; IMPAC Study Group.

Qual Life Res. 2002 Jun;11(4):329-38.

PMID:
12086118
41.

[Mediastinal liposarcoma. A report of 2 cases].

Ruiz LA, Camino J, Cabriada V, Campo A, Pascal I, Zalacain R.

Arch Bronconeumol. 1999 Apr;35(4):189-91. Spanish.

PMID:
10330542
42.

Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.

Zalacain R, Sobradillo V, Amilibia J, Barrón J, Achótegui V, Pijoan JI, Llorente JL.

Eur Respir J. 1999 Feb;13(2):343-8.

43.

[Pneumonia in the elderly].

Zalacain R, Camino J, Cabriada V.

Arch Bronconeumol. 1998 Nov;34 Suppl 2:63-7. Review. Spanish. No abstract available.

PMID:
9846215
44.

[Infection and chronic obstructive pulmonary disease].

Zalacain R.

Arch Bronconeumol. 1998 Oct;34(9):453-62. Review. Spanish. No abstract available.

PMID:
9842458
45.

[Usefulness of bronchoalveolar lavage in the renal transplant patient with suspected respiratory infection].

Ruiz LA, Gil P, Zalacain R, Cabriada V, Barrón J, García-Riego A, Llorente JL.

Arch Bronconeumol. 1998 Sep;34(8):388-93. Spanish.

PMID:
9803276
46.

[Initial empirical antibiotic treatment of community-acquired pneumonia].

Frías J, Gomis M, Prieto J, Mensa J, Bouza E, García-Rodríguez JA, Torres A, Dorca J, Zalacaín R, García de Lomas J.

Rev Esp Quimioter. 1998 Sep;11(3):255-61. Review. Spanish. No abstract available.

PMID:
9795313
47.

[Diagnosis and treatment of nosocomial pneumonia].

Torres A, de Celis MR, Bello S, Blanquer J, Dorca J, Molinos L, Verano A, Zalacaín R.

Arch Bronconeumol. 1997 Jul-Aug;33(7):346-50. Review. Spanish. No abstract available.

PMID:
9410436
48.

[The diagnosis and treatment of community-acquired pneumonia. SEPAR. Sociedad Española de Neumología y Cirugía Torácica].

Dorca J, Bello S, Blanquer J, de Celis R, Molinos L, Torres A, Verano A, Zalacain R.

Arch Bronconeumol. 1997 May;33(5):240-6. Spanish. No abstract available.

PMID:
9254171
49.

[Skin tumor as presentation form of lung actinomycosis].

Gil P, Ruiz LA, Pascal I, Camino J, Pocheville I, Zalacain R.

Arch Bronconeumol. 1997 Apr;33(4):198-200. Spanish.

PMID:
9280564
50.

[Peracetic acid: alternative to the sterilization of bronchofibroscopes].

Villate JI, Barrón J, Zalacaín R, Urcelay MI, Hernández JM, Argumedo M.

Arch Bronconeumol. 1997 Mar;33(3):133-5. Spanish.

PMID:
9181986

Supplemental Content

Loading ...
Support Center